1. Wang, Jingwen, Huang, Yuhong, Zhang, Jun, Yang, Jiayu, Tang, Jianwu. 2018. NRP-2 in tumor lymphangiogenesis and lymphatic metastasis. In Cancer letters, 418, 176-184. doi:10.1016/j.canlet.2018.01.040. https://pubmed.ncbi.nlm.nih.gov/29339213/
2. Liang, Xing-Qun, Avraham, Hava Karsenty, Jiang, Shuxian, Avraham, Shalom. . Retraction Note: Genetic alterations of the NRP/B gene are associated with human brain tumors. In Oncogene, 42, 2294. doi:10.1038/s41388-023-02741-3. https://pubmed.ncbi.nlm.nih.gov/37268860/
3. Soufivand, Parviz, Hosseini Torshizi, Ghazal, Roghani, Seyed Askar, Abdan, Zahra, Allahyari, Hosna. 2024. Conventional DMARDs therapy decreases disease activity and inflammation in newly diagnosed patients with rheumatoid arthritis by increasing FoxP3, Sema-3A, and Nrp-1 gene expression. In Inflammopharmacology, 32, 3687-3695. doi:10.1007/s10787-024-01565-1. https://pubmed.ncbi.nlm.nih.gov/39231852/
4. Wu, Qinchuan, Pan, Caixu, Zhou, Yuan, Zhou, Lin, Zheng, Shusen. 2023. Targeting neuropilin-1 abolishes anti-PD-1-upregulated regulatory T cells and synergizes with 4-1BB agonist for liver cancer treatment. In Hepatology (Baltimore, Md.), 78, 1402-1417. doi:10.1097/HEP.0000000000000320. https://pubmed.ncbi.nlm.nih.gov/36811396/
5. Ma, Xiao, Liu, Haonan, Shi, Congcong, Wang, Hongmei, Han, Zhengxiang. 2024. Bioinformatics analysis and clinical significance of NRP-1 in triple-negative breast cancer. In Heliyon, 10, e27368. doi:10.1016/j.heliyon.2024.e27368. https://pubmed.ncbi.nlm.nih.gov/38495206/
6. Kim, Aram, Mok, Bo Ram, Hahn, Soojung, Kim, Dong Hyun, Kim, Tae-Aug. . Alternative splicing variant of NRP/B promotes tumorigenesis of gastric cancer. In BMB reports, 55, 348-353. doi:. https://pubmed.ncbi.nlm.nih.gov/35725010/
智鼠故事 
